Pharma News

Keep updating your pharma knowledge
11 Mar 2019

Takeda subsidiary Millennium Pharmaceuticals Inc, sues Aurobindo to block generic Velcade

/
Posted By
/
Comments0
/

A U.S. unit of Japan’s Takeda Pharmaceutical Co has sued generic drugmaker Aurobindo Pharma Ltd over its plans to make a cheaper version of Takeda’s cancer drug Velcade.

In a lawsuit filed Wednesday in Delaware federal court, Takeda subsidiary Millennium Pharmaceuticals Inc said the proposed generic would infringe two of its Velcade patents that are set to expire in January 2022. It sought a court order blocking Aurobindo from selling the generic product before then.

Leave a Reply


The reCAPTCHA verification period has expired. Please reload the page.

Upskill Your Pharma Knowledge

Explore Next Gen Learning

Case Studies & Caselets | Simulation Based Learning | E-Lectures | Online Self Competency Assessments

Thank You for Subscription!